Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03718845 · ClinicalTrials.gov registry record
A Mind-Body Medicine Curriculum for Peer Counselors
A clinical trial of Anxiety, sponsored by The Center for Mind-Body Medicine.
- Completed
- Registry status
- 124
- Enrollment target
- 1
- Study location
NCT03718845: Completed study of Anxiety, sponsored by The Center for Mind-Body Medicine.
NCT03718845 is a study of Anxiety that has completed, run by The Center for Mind-Body Medicine. The registered enrollment target is 124 participants, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03718845, a study of Anxiety, has completed, sponsored by The Center for Mind-Body Medicine.
- COMPLETED
- Registry status
- 124 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will evaluate a Mind-Body Medicine curriculum for high school peer counselors in order to answer the following research questions: 1. Will peer counselor participation in the Mind-Body Medicine curriculum increase their sense of self-regulation, responsibility, social competence, and empathy; decrease anxiety; and increase hope? 2. What are the experiences of peer support counselors participating in the Mind-Body Medicine curriculum?
Primary Outcome
The State-Trait Anxiety Inventory has two subscales: State Anxiety and Trait Anxiety. Each has a minimum score of 20 and a maximum score of 80. Higher scores indicate more anxiety which is a worse outcome.
Conditions Studied
Interventions
- BEHAVIORAL Mind-Body Medicine Curriculum
Study Locations (1)
Florida
- Marjory Stoneman Douglas High School - Parkland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 124 participants |
| Start Date | 2018-10-22 |
| Est. Completion | 2019-06-30 |
What the finished NCT03718845 record still lists
NCT03718845 is an observational study that tracks outcomes without assigning an intervention. The registered 124 participants enrollment target is mid-sized for trials with a published cap, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (72% lower).
The record links to 1 condition, with Anxiety appearing as the primary indexed condition, and to 1 intervention - of which Mind-Body Medicine Curriculum is the first listed.
NCT03718845 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT03718845 about?
NCT03718845 is a clinical study titled "A Mind-Body Medicine Curriculum for Peer Counselors". This study will evaluate a Mind-Body Medicine curriculum for high school peer counselors in order to answer the following research questions: 1. Will peer counselor participation in the Mind-Body Medicine curriculum increase their sense of self-regulation, responsibility, social competence, and emp...
What is the current status of trial NCT03718845?
This trial is currently completed. The enrollment target is 124 participants. The study started on 2018-10-22. Estimated completion is 2019-06-30.
What conditions does trial NCT03718845 study?
This clinical trial studies the following conditions: Anxiety.
What interventions are being tested in trial NCT03718845?
The interventions under investigation include: Mind-Body Medicine Curriculum (BEHAVIORAL).
Who is sponsoring clinical trial NCT03718845?
This trial is sponsored by The Center for Mind-Body Medicine, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03718845 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anxiety
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03718845's enrollment target sits among peer trials
124 137th of 364 higher than 228 of 364 other Anxiety trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anxiety trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Acute and Long-Term Antidepressant Treatment Success in Adolescents With Anxiety (AtLAS-A)
RECRUITING · Phase 4
-
Focused Ultrasound for the Complex Patient
RECRUITING · NA
-
Digital Intervention for Physical Activity
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
-
Personalized Feedback Intervention for Latinx Drinkers With Anxiety
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523014 · 124 participants · Phase 2
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
- NCT02670707 · 124 participants · Phase 3
Vinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH)
- NCT02830724 · 124 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers
- NCT04748809 · 124 participants · NA
Effect of Anti-inflammatory Diet in Rheumatoid Arthritis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI